ArticleDiabetes, obesity & metabolism2023

Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses.

Mikhail N Kosiborod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.